Bolt Biotherapeutics
BOLT
BOLT
40 hedge funds and large institutions have $32.4M invested in Bolt Biotherapeutics in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 6 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
9% less funds holding
Funds holding: 44 → 40 (-4)
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
Holders
40
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.71M | |
| 2 | +$1.07M | |
| 3 | +$695K | |
| 4 |
Morgan Stanley
New York
|
+$377K |
| 5 |
JPMorgan Chase & Co
New York
|
+$235K |
Top Sellers
| 1 | -$364K | |
| 2 | -$156K | |
| 3 | -$52.3K | |
| 4 |
NM
Newtyn Management
New York
|
-$48.5K |
| 5 |
EP
Eversept Partners
New York
|
-$40.5K |